SignalChem enters a clinical trial collaboration with Merck to evaluate the effect of SLC-391 in combination with KEYTRUDA® (pembrolizumab) in advanced non-small cell lung cancer
March 25, 2021
March 25, 2021
March 8, 2021
December 21, 2020
December 10, 2020
October 22, 2020
October 14, 2020
July 7, 2020
June 25, 2020
June 11, 2020
January 9, 2026
Cycle Pharmaceuticals Ltd (Cycle) and Inceptua Group (Inceptua) have announced the expansion of their partnership to make NITYR® (nitisinone) tablets ...
December 4, 2025
The study reinforces that ME is a complex multisystemic condition with a clear genetic basis and lays the foundation for future clinical trials that c...
October 30, 2025
Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One™ solid-phase ...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225